Late Embolization of a Patent Foramen Ovale Occluder Successfully Retrieved Percutaneously Authors: Fadhel Nabil Hamidani, Horst Sievert, Mohammed Musallam, Lars Platschek, Stephan Hohmann, Blerim Berisha Published: 2026 ABSTRACT BackgroundPercutaneous patent foramen ovale (PFO) closure is an established therapy for secondary prevention of cryptogenic stroke. Device embolization is a rare but potentially serious complication, usually occurring early after implantation.Case SummaryA 68-year-old woman underwent PFO closure after ischemic stroke. At 3-month follow-up, the device was not visualized on transthoracic or transesophageal echocardiography. Computed tomography angiography revealed embolization to the distal abdominal aorta. The device was successfully retrieved using a percutaneous snare technique; retrieval was complicated by an infrarenal aortic dissection that was managed conservatively. Three weeks later, the patient experienced recurrent ischemic stroke and underwent repeat PFO closure with a larger device, without further complications.DiscussionPercutaneous retrieval is a feasible first-line strategy in hemodynamically stable patients. Careful anatomical assessment and appropriate device sizing are essential to reduce the risk of embolization.Take-Home MessagesThis case highlights the importance of appropriate PFO occluder sizing in patients with PFO and atrial septum aneurysm to minimize the risk of device embolization. Although retrieval of a PFO occluder embolized into the aorta carries a risk of aortic wall injury, a percutaneous approach should be considered the first-line management strategy. History of Presentation A 68-year-old woman without relevant prior medical history presented with an ischemic stroke in the territory of the right posterior cerebral artery. Diagnostic work-up revealed a patent foramen ovale (PFO). The Risk of Paradoxical Embolism score was moderate (<7); however, the probability of a PFO-associated stroke according to the PFO-Associated Stroke Causal Likelihood classification was high owing to the presence of an atrial septal aneurysm.Take-Home Messages•This case highlights the importance of appropriate PFO occluder sizing in patients with PFO and atrial septum aneurysm to minimize the risk of device embolization.•Although retrieval of a PFO occluder embolized into the aorta carries a risk of aortic wall injury, a percutaneous approach should be considered the first-line management strategy. Take-Home Messages •This case highlights the importance of appropriate PFO occluder sizing in patients with PFO and atrial septum aneurysm to minimize the risk of device embolization.•Although retrieval of a PFO occluder embolized into the aorta carries a risk of aortic wall injury, a percutaneous approach should be considered the first-line management strategy. •This case highlights the importance of appropriate PFO occluder sizing in patients with PFO and atrial septum aneurysm to minimize the risk of device embolization. This case highlights the importance of appropriate PFO occluder sizing in patients with PFO and atrial septum aneurysm to minimize the risk of device embolization. •Although retrieval of a PFO occluder embolized into the aorta carries a risk of aortic wall injury, a percutaneous approach should be considered the first-line management strategy. Although retrieval of a PFO occluder embolized into the aorta carries a risk of aortic wall injury, a percutaneous approach should be considered the first-line management strategy. PFO closure was performed using an 18/18 mm Amplatzer occluder (Abbott Laboratories) without immediate complications (Figure 1). Correct device position was shown on echocardiography before discharge. The patient was discharged on dual antiplatelet therapy.Figure 1Echocardiography of Implantation of an 18/18 mm Amplatzer PFO OccluderTransesophageal echocardiography before (A) and during (B) the procedure. Echocardiography of Implantation of an 18/18 mm Amplatzer PFO Occluder Transesophageal echocardiography before (A) and during (B) the procedure. At the scheduled 3-month follow-up, the occluder device could not be visualized on transthoracic or transesophageal echocardiography (Figure 2). A persistent left-to-right shunt was detected.Figure 2Follow-Up EchocardiographyAbsence of the occluder device on transthoracic (A) and transesophageal echocardiography (B) at 3-month follow-up. Follow-Up Echocardiography Absence of the occluder device on transthoracic (A) and transesophageal echocardiography (B) at 3-month follow-up. Investigations Transesophageal echocardiography confirmed absence of the device at the interatrial septum. Contrast-enhanced computed tomography demonstrated embolization of the occluder to the distal abdominal aorta at the level of L5, immediately proximal to the aortic bifurcation, without initial signs of vascular injury (Figure 3).Figure 3Computed Tomography Angiography Showing Embolized OccluderComputed tomography angiography demonstrating embolized occluder at the distal abdominal aorta near the bifurcation (A and B). Computed Tomography Angiography Showing Embolized Occluder Computed tomography angiography demonstrating embolized occluder at the distal abdominal aorta near the bifurcation (A and B). Management Endovascular retrieval was performed via right femoral arterial access with stepwise sheath upsizing to 16-F over an Amplatz Super Stiff Guidewire (Boston Scientific). An Amplatz Goose Neck Snare (Medtronic) captured 1 disc of the device, but retraction into the sheath was not feasible (Figure 4). An EN Snare Endovascular Snare System (Merit Medical) subsequently enabled secure engagement and withdrawal of the device into the sheath (Figure 5). Final extraction was completed using biopsy forceps (Figure 6).Figure 4Angiography Showing Amplatz Goose Neck SnareAmplatz Goose Neck Snare (A) capturing 1 disc of the embolized device (B).Figure 5Angiography Showing EN Snare Endovascular Snare SystemEN Snare Endovascular Snare System (A) retracting the device into the sheath (B).Figure 6Angiography Showing Final ExtractionFinal extraction of the occluder into the sheath using biopsy forceps (A and B). Angiography Showing Amplatz Goose Neck Snare Amplatz Goose Neck Snare (A) capturing 1 disc of the embolized device (B). Angiography Showing EN Snare Endovascular Snare System EN Snare Endovascular Snare System (A) retracting the device into the sheath (B). Angiography Showing Final Extraction Final extraction of the occluder into the sheath using biopsy forceps (A and B). Angiography obtained before sheath removal demonstrated an infrarenal aortic dissection (Figure 7). The patient remained hemodynamically stable and was managed conservatively.Figure 7Angiography Showing Infrarenal Aortic DissectionCompletion angiography demonstrating infrarenal aortic dissection (A) confirmed in computed tomography angiography (B). Angiography Showing Infrarenal Aortic Dissection Completion angiography demonstrating infrarenal aortic dissection (A) confirmed in computed tomography angiography (B). Outcome and Follow-Up Postprocedural computed tomography angiography confirmed a long-segment dissection of the infrarenal aorta extending into the right common iliac artery without malperfusion. The patient was discharged after 3 days. Follow-up imaging obtained 9 days later showed no progression. Three weeks after retrieval, the patient experienced recurrent ischemic stroke. Repeat PFO closure using a larger Amplatzer Talisman occluder (35/25 mm) (Abbott Laboratories) was performed without complications (Figure 8). Subsequent imaging demonstrated regression of the infrarenal dissection (Figure 9). Echocardiography obtained at 3-month follow-up confirmed correct device position without residual shunt (Figure 10).Figure 8Repeat PFO Closure Using a 35/25 mm Amplatzer Talisman OccluderFigure 9Follow-Up Computed Tomography Angiography Showing Regression of Infrarenal Dissection and Stable Iliac InvolvementFigure 10Transthoracic Echocardiography at 3-Month Follow-Up Confirming Correct Device Position Without Residual Shunt Repeat PFO Closure Using a 35/25 mm Amplatzer Talisman Occluder Follow-Up Computed Tomography Angiography Showing Regression of Infrarenal Dissection and Stable Iliac Involvement Transthoracic Echocardiography at 3-Month Follow-Up Confirming Correct Device Position Without Residual Shunt Discussion Randomized trials including RESPECT, CLOSE, and REDUCE established PFO closure as superior to medical therapy in selected patients with cryptogenic stroke.1, 2, 3, 4 Device embolization remains rare and typically occurs early after the procedure. In a large single-center cohort, periprocedural device embolization occurred in 2 of 310 patients.5 Late embolization after apparently uncomplicated discharge is considerably less frequent,6,7 and no instances have been reported in randomized controlled trials for PFO closure.1, 2, 3 Mechanisms include device undersizing, atrial septal aneurysm, deficient septal rims, and inadequate anchoring. In our case, the most likely explanation is an inappropriate device size and suboptimal positioning during deployment in the presence of a septal aneurysm with inadequate tissue rims. Our tendency to avoid occluder device oversizing to prevent complications such as erosion or injury to the aortic root or the mitral and tricuspid valves probably led us to select a smaller occluder device. Careful anatomical assessment and appropriate device selection are therefore essential. Cross-sectional imaging should be performed promptly when device absence is suspected. Snare-based percutaneous retrieval is effective and avoids open surgical removal, although vascular injury remains a risk. In principle, all occluder devices can be retrieved using sheaths that are 2-F sizes larger than their recommended delivery sheath.8 A previous report recommended the use of a 24-F sheath to reduce the tension required for device retrieval into the sheath.9 However, embolized occluder devices may undergo substantial deformation when being pulled to the sheath during retrieval, and in some cases the occluder device cannot be retrieved past the iliac bifurcation. In our case, we used a long 16-F sheath to reduce procedural difficulty. Subsequently, the device was manipulated with biopsy forceps and snared several times while attempting to reposition it into the sheath. This process likely caused damage to the aortic intima. Furthermore, the development of adhesions between the migrated device and the aortic wall may also have contributed to the development of aortic dissection. In stable patients without malperfusion or progression, conservative management of limited infrarenal dissection may be appropriate under close follow-up. In our case, the occurrence of recurrent ischemic stroke after retrieval of the PFO occluder supports the initial diagnosis of a PFO-associated stroke according to the PFO-Associated Stroke Causal Likelihood classification. Conclusions Late embolization of a PFO occluder to the abdominal aorta is rare but potentially serious. Percutaneous retrieval should be considered first-line treatment in stable patients. Proper device sizing is critical to prevent embolization. Funding Support and Author Disclosures Dr Hohmann has reported honoraria from Boehringer Ingelheim, Medtronic, and Abbott, all outside the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.Visual SummaryTimeline of CaseTimelineEventsDate of submission/Day 1A 68-year-old woman without relevant prior medical history presented with an ischemic stroke in the territory of the right posterior cerebral artery.Transesophageal echocardiography revealed a patent foramen ovale associated with stroke according to the Risk of Paradoxical Embolism score and PFO-Associated Stroke Causal Likelihood classification.Day 68Patent foramen ovale closure was performed using an 18/18 mm Amplatzer occluder (Abbott Laboratories) without immediate complications.Day 69Echocardiography showed correct device position.The patient was discharged on dual antiplatelet therapy.Day 193 (3-month follow-up)The occluder device could not be visualized on transthoracic or transesophageal echocardiography.Computed tomography demonstrated embolization of the occluder to the distal abdominal aorta at the level of L5.Day 194Endovascular retrieval was performed via right femoral arterial access with stepwise sheath upsizing to 16-F over an Amplatz Super Stiff Guidewire (Boston Scientific).Angiography obtained before sheath removal demonstrated an infrarenal aortic dissection.Day 209The patient remained hemodynamically stable and was managed conservatively.The patient was discharged.Day 260 (3 weeks after retrieval)Recurrent ischemic stroke occurred.Repeat patent foramen ovale closure using a larger Amplatzer Talisman occluder (35/25 mm) (Abbott Laboratories) was performed without complications.Day 285 (3-month follow-up)Echocardiography confirmed correct device position without residual shunt.Computed tomography demonstrated regression of the infrarenal dissection. Visual SummaryTimeline of CaseTimelineEventsDate of submission/Day 1A 68-year-old woman without relevant prior medical history presented with an ischemic stroke in the territory of the right posterior cerebral artery.Transesophageal echocardiography revealed a patent foramen ovale associated with stroke according to the Risk of Paradoxical Embolism score and PFO-Associated Stroke Causal Likelihood classification.Day 68Patent foramen ovale closure was performed using an 18/18 mm Amplatzer occluder (Abbott Laboratories) without immediate complications.Day 69Echocardiography showed correct device position.The patient was discharged on dual antiplatelet therapy.Day 193 (3-month follow-up)The occluder device could not be visualized on transthoracic or transesophageal echocardiography.Computed tomography demonstrated embolization of the occluder to the distal abdominal aorta at the level of L5.Day 194Endovascular retrieval was performed via right femoral arterial access with stepwise sheath upsizing to 16-F over an Amplatz Super Stiff Guidewire (Boston Scientific).Angiography obtained before sheath removal demonstrated an infrarenal aortic dissection.Day 209The patient remained hemodynamically stable and was managed conservatively.The patient was discharged.Day 260 (3 weeks after retrieval)Recurrent ischemic stroke occurred.Repeat patent foramen ovale closure using a larger Amplatzer Talisman occluder (35/25 mm) (Abbott Laboratories) was performed without complications.Day 285 (3-month follow-up)Echocardiography confirmed correct device position without residual shunt.Computed tomography demonstrated regression of the infrarenal dissection. Timeline of Case